Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	101.54	264.55	54.9	32.67	200.7
Short-Term Investments	926.35	1,090	503.66	301.75	133.01
Cash & Short-Term Investments	1,028	1,354	558.56	334.43	333.71
Cash Growth	-24.09%	142.42%	67.02%	0.21%	95.29%
Accounts Receivable	0.59	-	-	-	-
Other Receivables	-	8.47	9.26	2.9	1.48
Receivables	0.59	8.47	9.26	2.9	1.48
Inventory	2.02	-	-	-	-
Prepaid Expenses	17.84	10.43	4.56	3.51	7.2
Restricted Cash	-	0.5	-	-	-
Other Current Assets	-	1.92	1.78	4.36	2.34
Total Current Assets	1,048	1,375	574.15	345.18	344.72
Property, Plant & Equipment	54.79	55.58	57.43	4.99	4.72
Long-Term Investments	-	2	0.47	-	1.01
Other Long-Term Assets	23.13	1.63	3.3	2.01	0.57
Total Assets	1,126	1,435	635.35	352.18	351.02
Accounts Payable	41.77	5.85	6.55	6.88	3.42
Accrued Expenses	35.58	44.49	27.35	17.19	11.63
Current Portion of Leases	6.49	7.15	4.17	1.05	0.94
Current Unearned Revenue	1.24	2.18	2.06	2.24	-
Other Current Liabilities	-	0.01	3.82	0.36	-
Total Current Liabilities	85.07	59.68	43.94	27.72	16
Long-Term Leases	42.05	44.57	47.56	2.02	3.07
Long-Term Unearned Revenue	3.81	4.7	4.75	6.1	-
Other Long-Term Liabilities	3.24	0.83	-	-	0
Total Liabilities	134.17	109.79	96.25	35.85	19.07
Common Stock	2,408	2,276	1,192	759.43	607.58
Retained Earnings	-1,417	-952.11	-653.7	-439.17	-275.26
Comprehensive Income & Other	1.75	0.96	0.98	-3.93	-0.38
Total Common Equity	992.08	1,325	539.11	316.33	331.94
Shareholders' Equity	992.08	1,325	539.11	316.33	331.94
Total Liabilities & Equity	1,126	1,435	635.35	352.18	351.02
Total Debt	48.54	51.72	51.73	3.08	4.01
Net Cash (Debt)	979.35	1,302	506.83	331.35	329.69
Net Cash Growth	-24.80%	156.96%	52.96%	0.50%	98.57%
Net Cash Per Share	10.41	16.12	8.73	6.37	8.58
Filing Date Shares Outstanding	104.71	93.05	69.6	53.91	47.78
Total Common Shares Outstanding	95.58	92.93	68.18	53.88	47.6
Working Capital	963.27	1,316	530.21	317.46	328.73
Book Value Per Share	10.38	14.26	7.91	5.87	6.97
Tangible Book Value	992.08	1,325	539.11	316.33	331.94
Tangible Book Value Per Share	10.38	14.26	7.91	5.87	6.97
Machinery	-	7.9	6.11	4.07	2.79
Leasehold Improvements	-	11.9	9.84	3.52	3.52

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q